
Dave Trong Nguyen
Supervisory Patent Examiner (ID: 14876, Phone: (571)272-0731 , Office: P/1634 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1804, 1634, 1621, 1632 |
| Total Applications | 624 |
| Issued Applications | 320 |
| Pending Applications | 143 |
| Abandoned Applications | 162 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17113115
[patent_doc_number] => 20210293712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD FOR FLUOROMETRIC ASSAY IN CELL-FREE PROTEIN SYNTHESIS ENVIRONMENT
[patent_app_type] => utility
[patent_app_number] => 17/264316
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 404
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264316 | METHOD FOR FLUOROMETRIC ASSAY IN CELL-FREE PROTEIN SYNTHESIS ENVIRONMENT | Aug 6, 2020 | Abandoned |
Array
(
[id] => 16468582
[patent_doc_number] => 20200370119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => Synaptojanin 2 (SYNJ2) Variants And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/881167
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881167 | Synaptojanin 2 (SYNJ2) Variants And Uses Thereof | May 21, 2020 | Abandoned |
Array
(
[id] => 15899023
[patent_doc_number] => 20200149030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => MOBILE DEVICE FOR THE ISOLATION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/738300
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16738300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/738300 | MOBILE DEVICE FOR THE ISOLATION OF NUCLEIC ACIDS | Jan 8, 2020 | Abandoned |
Array
(
[id] => 15832609
[patent_doc_number] => 20200131586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSING OR DETECTING LUNG CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/725767
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725767
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725767 | METHODS AND COMPOSITIONS FOR DIAGNOSING OR DETECTING LUNG CANCERS | Dec 22, 2019 | Abandoned |
Array
(
[id] => 14903909
[patent_doc_number] => 20190295720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => IMMUNE CELL SIGNATURES
[patent_app_type] => utility
[patent_app_number] => 16/358576
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16358576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/358576 | IMMUNE CELL SIGNATURES | Mar 18, 2019 | Abandoned |
Array
(
[id] => 14868729
[patent_doc_number] => 20190284606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PROCESSING POLYNUCLEOTIDE-CONTAINING SAMPLES
[patent_app_type] => utility
[patent_app_number] => 16/283617
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283617 | PROCESSING POLYNUCLEOTIDE-CONTAINING SAMPLES | Feb 21, 2019 | Abandoned |
Array
(
[id] => 14685709
[patent_doc_number] => 20190241969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING THYROID TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/277950
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16277950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/277950 | COMPOSITIONS AND METHODS FOR DIAGNOSING THYROID TUMORS | Feb 14, 2019 | Abandoned |
Array
(
[id] => 14582017
[patent_doc_number] => 20190218617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => PROGNOSTIC METHOD
[patent_app_type] => utility
[patent_app_number] => 16/216750
[patent_app_country] => US
[patent_app_date] => 2018-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16216750
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/216750 | PROGNOSTIC METHOD | Dec 10, 2018 | Abandoned |
Array
(
[id] => 16484357
[patent_doc_number] => 20200377958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => BIOMARKERS AND METHODS FOR TREATMENT WITH NAE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/766397
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -94
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766397 | BIOMARKERS AND METHODS FOR TREATMENT WITH NAE INHIBITORS | Nov 29, 2018 | Abandoned |
Array
(
[id] => 17052578
[patent_doc_number] => 20210262012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => METHODS FOR THE COMPREHENSIVE IDENTIFICATION OF ANTIMICROBIAL RESISTANCE MARKERS BY SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 16/762303
[patent_app_country] => US
[patent_app_date] => 2018-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762303 | METHODS FOR THE COMPREHENSIVE IDENTIFICATION OF ANTIMICROBIAL RESISTANCE MARKERS BY SEQUENCING | Nov 6, 2018 | Abandoned |
Array
(
[id] => 13827269
[patent_doc_number] => 20190017119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => Genetic Risk Predictor
[patent_app_type] => utility
[patent_app_number] => 16/034260
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034260 | Genetic Risk Predictor | Jul 11, 2018 | Abandoned |
Array
(
[id] => 16762672
[patent_doc_number] => 20210108253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => QUANTIFICATION OF NGS DNA BY ADAPTER SEQUENCE
[patent_app_type] => utility
[patent_app_number] => 16/497615
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497615 | QUANTIFICATION OF NGS DNA BY ADAPTER SEQUENCE | Mar 28, 2018 | Abandoned |
Array
(
[id] => 15324841
[patent_doc_number] => 20200002750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => METHODS FOR DETECTING C. CANIMORSUS CAPSULAR SEROTYPES IN A SAMPLE
[patent_app_type] => utility
[patent_app_number] => 16/482769
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/482769 | METHODS FOR DETECTING C. CANIMORSUS CAPSULAR SEROTYPES IN A SAMPLE | Feb 15, 2018 | Abandoned |
Array
(
[id] => 15994219
[patent_doc_number] => 20200172980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => PROSTATIC CANCER MARKER, PCDH9, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/481311
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481311 | PROSTATIC CANCER MARKER, PCDH9, AND APPLICATION THEREOF | Dec 14, 2017 | Abandoned |
Array
(
[id] => 15554411
[patent_doc_number] => 20200061617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => DEVICES AND METHODS FOR NUCLEIC ACID IDENTIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/467347
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467347 | DEVICES AND METHODS FOR NUCLEIC ACID IDENTIFICATION | Dec 6, 2017 | Abandoned |
Array
(
[id] => 14468605
[patent_doc_number] => 20190185945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => Biomarkers of Oral, Pharyngeal and Laryngeal Cancers
[patent_app_type] => utility
[patent_app_number] => 16/326140
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326140 | Biomarkers of Oral, Pharyngeal and Laryngeal Cancers | Aug 17, 2017 | Abandoned |
Array
(
[id] => 16013721
[patent_doc_number] => 20200181703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIES CARDIAC DEVELOPMENTAL GENE PATTERNING AND A NOVEL CLASS OF BIOMARKERS FOR HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/315129
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315129
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315129 | EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIES CARDIAC DEVELOPMENTAL GENE PATTERNING AND A NOVEL CLASS OF BIOMARKERS FOR HEART FAILURE | Jul 5, 2017 | Abandoned |
Array
(
[id] => 14343159
[patent_doc_number] => 20190153552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => HPV SCREENING PLATFORM
[patent_app_type] => utility
[patent_app_number] => 16/300398
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300398
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300398 | HPV SCREENING PLATFORM | May 9, 2017 | Abandoned |
Array
(
[id] => 14187611
[patent_doc_number] => 20190113510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => BIOLOGICAL MATERIAL ANALYSIS DEVICE, BIOLOGICAL MATERIAL ANALYSIS SYSTEM, BIOLOGICAL MATERIAL SELECTION METHOD, BIOLOGICAL MATERIAL ANALYSIS PROGRAM, AND CELL CULTURE VESSEL
[patent_app_type] => utility
[patent_app_number] => 16/099869
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099869
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099869 | BIOLOGICAL MATERIAL ANALYSIS DEVICE, BIOLOGICAL MATERIAL ANALYSIS SYSTEM, BIOLOGICAL MATERIAL SELECTION METHOD, BIOLOGICAL MATERIAL ANALYSIS PROGRAM, AND CELL CULTURE VESSEL | Apr 12, 2017 | Abandoned |
Array
(
[id] => 14185903
[patent_doc_number] => 20190112656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => MITOCHONDRIAL BIOMARKER REFLECTING AGING
[patent_app_type] => utility
[patent_app_number] => 16/088596
[patent_app_country] => US
[patent_app_date] => 2017-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088596 | MITOCHONDRIAL BIOMARKER REFLECTING AGING | Mar 24, 2017 | Abandoned |